Screener
Rapport Therapeutics, Inc. RAPP EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For The Six Months Ended June 30, 2026 | For The Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest income | 4,191 | 2,764 | 8,549 | 5,809 |
| Total other income | 4,191 | 2,764 | 8,549 | 5,809 |
| Net loss | $(56,615) | $(26,732) | $(76,472) | $(50,795) |
| Net loss per share attributable to common stockholders, basic and diluted | $(1.19) | $(0.75) | $(1.61) | $(1.44) |
| Weighted-average common shares outstanding, basic and diluted | 47,473,174 | 35,444,635 | 47,355,550 | 35,356,098 |
| Comprehensive loss: | ||||
| Net loss | $(56,615) | $(26,732) | $(76,472) | $(50,795) |
| Change in unrealized (losses) gains on investments, net of tax | (765) | 19 | (1,816) | 446 |
Item 1. Financial Statements.
FAQ
- What is Rapport Therapeutics, Inc.'s EPS (basic)?
- Rapport Therapeutics, Inc. (RAPP) reported EPS (basic) of -$1.19 in Q2 2026.
- How has Rapport Therapeutics, Inc.'s EPS (basic) changed year-over-year?
- Rapport Therapeutics, Inc.'s EPS (basic) decreased by 58.7% year-over-year, from -$0.75 to -$1.19.
- What is the long-term trend for Rapport Therapeutics, Inc.'s EPS (basic)?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s EPS (basic) has grown at a -64.9% compound annual growth rate (CAGR), from -$23.10 to -$2.85.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about Rapport Therapeutics, Inc.'s eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude